Dr. Shin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-9697Fax+1 410-955-2108
Education & Training
- Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2007 - 2009
- Johns Hopkins UniversityFellowship, Gastroenterology, 2004 - 2008
- Johns Hopkins UniversityResidency, Internal Medicine, 2001 - 2004
- Duke University School of MedicineClass of 2001
Certifications & Licensure
- MD State Medical License 2008 - 2025
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses Start of enrollment: 2018 Apr 12
Publications & Presentations
PubMed
- 55 citationsRe-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: exp...Aaron T. Wild, Susan M. Hiniker, Daniel T. Chang, Phuoc T. Tran, Mouen A. Khashab
Journal of Gastrointestinal Oncology. 2013-09-08 - 33 citationsLinear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem studyEun Ji Shin, Mark Topazian, Michael Goggins, Sapna Syngal, John R. Saltzman
Gastrointestinal Endoscopy. 2015-11-01 - 45 citationsSurgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.Marcia I. Canto, Tossapol Kerdsirichairat, Charles J. Yeo, Ralph H. Hruban, Eun Ji Shin
Journal of Gastrointestinal Surgery. 2020-05-01
Authored Content
- Mo1276 VISIBILITY, ARTIFACT AND MIGRATIONS USING THREE TYPES OF FIDUCIALS FOR PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) PATIENTS RECEIVING STEREOTACTIC BODY RADIATION THERAPY (SBRT)May 2018
- Mo1276 VISIBILITY, ARTIFACT AND MIGRATIONS USING THREE TYPES OF FIDUCIALS FOR PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) PATIENTS RECEIVING STEREOTACTIC BODY RADIATION THERAPY (SBRT)May 2018
Other Languages
- Korean
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/eun-shin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: